Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

GANCICLOVIR FOR INJECTION USP DIN 02538911

Status: Approved
Holder: EUGIA PHARMA INC.
Molecule: GANCICLOVIR (GANCICLOVIR SODIUM)

Health Canada record

Active ingredient(s)GANCICLOVIR (GANCICLOVIR SODIUM) 500 MG
Dosage formPowder For Solution
RouteIntravenous
SchedulePRESCRIPTION
ClassHuman
ATCJ05AB06 GANCICLOVIR
Original market date
Current status date16-Jun-2023
SourceHealth Canada DPD

Establishment licence of the holder

Eugia Pharma Inc. — licence 3-002768, currently licensed, last inspection rating C (2026-02-04).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing GANCICLOVIR (GANCICLOVIR SODIUM)

DINProductCompanyFormStrengthStatus
02162695CYTOVENECHEPLAPHARM ARZNEIMITTEL GMBHPowder For SolutionGANCICLOVIR (GANCICLOVIR SODIUM) 500 MGMarketed
02537168GANCICLOVIR FOR INJECTIONFORMATIVE PHARMA INC.Powder For SolutionGANCICLOVIR (GANCICLOVIR SODIUM) 500 MGMarketed
02471930GANCICLOVIR FOR INJECTION USPAURO PHARMA INCPowder For SolutionGANCICLOVIR (GANCICLOVIR SODIUM) 500 MGApproved
02475391GANCICLOVIR FOR INJECTION USPSTERIMAX INCPowder For SolutionGANCICLOVIR (GANCICLOVIR SODIUM) 500 MGMarketed
02404761GANCICLOVIR FOR INJECTION, USPFRESENIUS KABI CANADA LTDPowder For SolutionGANCICLOVIR (GANCICLOVIR SODIUM) 500 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
310072023-06-16Abbreviated New Drug Submission (ANDS)Administrative: Licensing Agreement Between Two Manufacturers
Request a quote for GANCICLOVIR FOR INJECTION USP

How to read a Canadian DIN record